GEVA PHARMA
ActiveSummary
GEVA PHARMA has been active since 1985 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €190,377 and a net result of €81,596. Equity is shrinking by about 4.7% per year across the filed financial years. Its solvency ranks better than 42% of 12,661 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Group and network
Connections & network
3 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
DECAPHAR
Shared corporate director
→
VERZELE PHARMA
Shared corporate director
→
VERZELE PHARMA ZWALM
Shared corporate director
→